Quest Diagnostics (DGX) Revenue & Revenue Breakdown
Quest Diagnostics Revenue Highlights
Latest Revenue (Y)
$9.87B
Latest Revenue (Q)
$2.82B
Main Segment (Y)
Diagnostic Information Services Business
Quest Diagnostics Revenue by Period
Quest Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $9.87B | 6.70% |
| 2023-12-31 | $9.25B | -6.38% |
| 2022-12-31 | $9.88B | -8.39% |
| 2021-12-31 | $10.79B | 14.32% |
| 2020-12-31 | $9.44B | 22.15% |
| 2019-12-31 | $7.73B | 2.59% |
| 2018-12-31 | $7.53B | -2.31% |
| 2017-12-31 | $7.71B | 2.58% |
| 2016-12-31 | $7.51B | 0.29% |
| 2015-12-31 | $7.49B | 0.78% |
| 2014-12-31 | $7.43B | 4.04% |
| 2013-12-31 | $7.15B | -3.20% |
| 2012-12-31 | $7.38B | -1.70% |
| 2011-12-31 | $7.51B | 1.92% |
| 2010-12-31 | $7.37B | -1.16% |
| 2009-12-31 | $7.46B | 2.84% |
| 2008-12-31 | $7.25B | 8.12% |
| 2007-12-31 | $6.70B | 6.96% |
| 2006-12-31 | $6.27B | 13.90% |
| 2005-12-31 | $5.50B | 7.36% |
| 2004-12-31 | $5.13B | 8.20% |
| 2003-12-31 | $4.74B | 15.33% |
| 2002-12-31 | $4.11B | 13.24% |
| 2001-12-31 | $3.63B | 6.04% |
| 2000-12-31 | $3.42B | 55.14% |
| 1999-12-31 | $2.21B | 51.19% |
| 1998-12-31 | $1.46B | -4.59% |
| 1997-12-31 | $1.53B | -5.42% |
| 1996-12-31 | $1.62B | - |
Quest Diagnostics generated $9.87B in revenue during NA 2024, up 6.70% compared to the previous quarter, and up 127.78% compared to the same period a year ago.
Quest Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $2.82B | 1.99% |
| 2025-06-30 | $2.76B | 4.11% |
| 2025-03-31 | $2.65B | 1.18% |
| 2024-12-31 | $2.62B | 5.35% |
| 2024-09-30 | $2.49B | 3.80% |
| 2024-06-30 | $2.40B | 1.31% |
| 2024-03-31 | $2.37B | 3.41% |
| 2023-12-31 | $2.29B | -0.31% |
| 2023-09-30 | $2.29B | -1.84% |
| 2023-06-30 | $2.34B | 0.30% |
| 2023-03-31 | $2.33B | -0.09% |
| 2022-12-31 | $2.33B | -6.15% |
| 2022-09-30 | $2.49B | 1.35% |
| 2022-06-30 | $2.45B | -6.05% |
| 2022-03-31 | $2.61B | -4.85% |
| 2021-12-31 | $2.74B | -1.08% |
| 2021-09-30 | $2.77B | 8.78% |
| 2021-06-30 | $2.55B | -6.25% |
| 2021-03-31 | $2.72B | -9.39% |
| 2020-12-31 | $3.00B | 7.75% |
| 2020-09-30 | $2.79B | 52.49% |
| 2020-06-30 | $1.83B | 0.27% |
| 2020-03-31 | $1.82B | -5.40% |
| 2019-12-31 | $1.93B | -1.53% |
| 2019-09-30 | $1.96B | 0.15% |
| 2019-06-30 | $1.95B | 3.28% |
| 2019-03-31 | $1.89B | 2.83% |
| 2018-12-31 | $1.84B | -2.65% |
| 2018-09-30 | $1.89B | -1.56% |
| 2018-06-30 | $1.92B | 1.86% |
| 2018-03-31 | $1.88B | -2.69% |
| 2017-12-31 | $1.94B | 0.26% |
| 2017-09-30 | $1.93B | -0.62% |
| 2017-06-30 | $1.94B | 2.32% |
| 2017-03-31 | $1.90B | 2.04% |
| 2016-12-31 | $1.86B | -1.27% |
| 2016-09-30 | $1.89B | -1.10% |
| 2016-06-30 | $1.91B | 2.31% |
| 2016-03-31 | $1.86B | 0.76% |
| 2015-12-31 | $1.85B | -1.65% |
| 2015-09-30 | $1.88B | -2.34% |
| 2015-06-30 | $1.93B | 4.68% |
| 2015-03-31 | $1.84B | -2.34% |
| 2014-12-31 | $1.88B | -1.10% |
| 2014-09-30 | $1.90B | 0.11% |
| 2014-06-30 | $1.90B | 8.93% |
| 2014-03-31 | $1.75B | -0.60% |
| 2013-12-31 | $1.76B | -1.72% |
| 2013-09-30 | $1.79B | -1.58% |
| 2013-06-30 | $1.82B | 1.63% |
| 2013-03-31 | $1.79B | 5.85% |
| 2012-12-31 | $1.69B | -8.84% |
| 2012-09-30 | $1.85B | -2.90% |
| 2012-06-30 | $1.91B | -1.53% |
| 2012-03-31 | $1.94B | 3.04% |
| 2011-12-31 | $1.88B | -1.42% |
| 2011-09-30 | $1.91B | 0.17% |
| 2011-06-30 | $1.90B | 4.48% |
| 2011-03-31 | $1.82B | -0.14% |
| 2010-12-31 | $1.82B | -2.18% |
| 2010-09-30 | $1.86B | -0.54% |
| 2010-06-30 | $1.87B | 3.83% |
| 2010-03-31 | $1.81B | -2.31% |
| 2009-12-31 | $1.85B | -2.58% |
| 2009-09-30 | $1.90B | -0.25% |
| 2009-06-30 | $1.90B | 5.19% |
| 2009-03-31 | $1.81B | 0.43% |
| 2008-12-31 | $1.80B | -1.44% |
| 2008-09-30 | $1.83B | -0.61% |
| 2008-06-30 | $1.84B | 2.98% |
| 2008-03-31 | $1.78B | - |
Quest Diagnostics generated $2.82B in revenue during Q3 2025, up 1.99% compared to the previous quarter, and up 117.48% compared to the same period a year ago.
Quest Diagnostics Revenue Breakdown
Quest Diagnostics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Diagnostic Information Services Business | $9.61B | $8.98B | $9.61B | - | - |
| Other Segments | - | $276.00M | $274.00M | - | - |
| Anatomic pathology testing services | - | - | - | $553.00M | $482.00M |
| COVID-19 Testing Services | - | - | - | $2.77B | $2.72B |
| Gene-based and esoteric testing services | - | - | - | $2.88B | $2.10B |
| Routine clinical testing services | - | - | - | $4.29B | $3.84B |
| All other services | - | - | - | $294.00M | $298.00M |
Latest
Quest Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Diagnostic Information Services Business (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Information Services Business | $2.75B | $2.70B | $2.59B | $4.85B | $2.43B | $2.33B | $2.22B | $2.23B | $2.27B | $2.26B | $2.27B | $2.92B | $2.71B | - | - | - | - | - | - | - |
| Other Segments | - | - | - | - | - | - | $67.00M | $67.00M | $70.00M | $72.00M | $68.00M | $80.00M | $77.00M | - | - | - | - | - | - | - |
| Gene-based and esoteric testing services | - | - | - | - | - | - | - | - | - | - | - | $835.00M | $787.00M | $739.00M | $906.00M | $646.00M | $673.00M | $653.00M | - | - |
| COVID-19 Testing Services | - | - | - | - | - | - | - | - | - | - | - | $316.00M | $355.00M | $599.00M | $722.00M | $709.00M | $511.00M | $828.00M | - | - |
| All other services | - | - | - | - | - | - | - | - | - | - | - | $67.00M | $69.00M | $70.00M | $70.00M | $71.00M | $76.00M | $77.00M | - | - |
| Anatomic pathology testing services | - | - | - | - | - | - | - | - | - | - | - | $149.00M | $144.00M | $137.00M | $145.00M | $138.00M | $140.00M | $130.00M | - | - |
| Routine clinical testing and other services | - | - | - | - | - | - | - | - | - | - | - | $1.12B | $1.10B | $1.07B | - | - | - | - | - | - |
| Routine clinical testing services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $901.00M | $1.21B | $1.15B | $1.03B | - | - |
Latest
Quest Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Diagnostic Information Services Business (100.00%).
Quest Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GMAB | Genmab | $16.47B | $4.14B |
| LH | Labcorp | $12.16B | $3.53B |
| DGX | Quest Diagnostics | $9.87B | $2.82B |
| BIIB | Biogen | $9.68B | $2.65B |
| ICLR | ICON Public | $8.12B | $2.09B |
| MTD | Mettler-Toledo | $3.87B | $983.22M |
| WAT | Waters | $2.96B | $771.33M |
| WST | West Pharmaceutical Services | $2.89B | $804.70M |
| UTHR | United Therapeutics | $2.88B | $798.60M |
| ZBH | Zimmer Biomet | $2.02B | - |
| NTRA | Natera | $1.70B | $501.83M |